ClinicalTrials.govpublic full text
A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
rheumatoid arthritis, cdp870, certolizumab pegol, cimzia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 870739
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.